Back to Search
JESSICA TREADWAY, PHARMD
PHARMD
Pharmacist
NPI: 1578859492Individual
Specialties, Licenses & Credentials
Research & Publications (20)
(3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone: a potent, selective, orally active dipeptidyl peptidase IV inhibitor.
PMID 19275964·Bioorg Med Chem Lett·2009
7-preclinical
Piperidinyl-2-phenethylamino inhibitors of DPP-IV for the treatment of type 2 diabetes.
PMID 19285862·Bioorg Med Chem Lett·2009
4-observational
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.
PMID 17194716·Drug Metab Dispos·2007
8-other
Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*,S*]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide).
PMID 17251391·J Pharmacol Exp Ther·2007
7-preclinical
(3R,4S)-4-(2,4,5-Trifluorophenyl)-pyrrolidin-3-ylamine inhibitors of dipeptidyl peptidase IV: synthesis, in vitro, in vivo, and X-ray crystallographic characterization.
PMID 17822893·Bioorg Med Chem Lett·2007
7-preclinical
The hepatic PP1 glycogen-targeting subunit interaction with phosphorylase a can be blocked by C-terminal tyrosine deletion or an indole drug.
PMID 17870073·FEBS Lett·2007
7-preclinical
Structural basis for near unity quantum yield core/shell nanostructures.
PMID 16834437·Nano Lett·2006
8-other
Establishment of correlation between in vitro enzyme binding potency and in vivo pharmacological activity: application to liver glycogen phosphorylase a inhibitors.
PMID 16537796·J Pharmacol Exp Ther·2006
7-preclinical
cis-2,5-dicyanopyrrolidine inhibitors of dipeptidyl peptidase IV: synthesis and in vitro, in vivo, and X-ray crystallographic characterization.
PMID 16722626·J Med Chem·2006
7-preclinical
5-Chloroindoloyl glycine amide inhibitors of glycogen phosphorylase: synthesis, in vitro, in vivo, and X-ray crystallographic characterization.
PMID 15603973·Bioorg Med Chem Lett·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 80 DAMANTE DR
CONCORD, NH 03301 - Phone
- (603) 227-0816
Quick Facts
- NPI
- 1578859492
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile